Revision history of "OPTIMISATION OF THE TREATMENT OF ACUTE GVHD WITH STROMAL MESENCHYMAL CELLS OF ADIPOCYTIC ORIGIN" (Q3161222)

9 October 2024

• curprev 22:5322:53, 9 October 2024‎ DG Regio talk contribs‎ 82,259 bytes +2‎ ‎Changed label, description and/or aliases in pt
• curprev 22:5322:53, 9 October 2024‎ DG Regio talk contribs‎ 82,257 bytes +55‎ ‎Set a claim value: summary (P836): O transplante alogénico é a única opção terapêutica para muitos doentes com hemopatias malignas. Os seus resultados são limitados pela sua elevada toxicidade, sendo a doença do enxerto contra o hospedeiro (GHD) a principal causa de morbilidade e mortalidade. A GVHD ocorre em 30-70 % dos doentes; destes, até 80 % não respondem ou têm uma recaída após a primeira linha de tratamento (corticóides) e a sua sobrevivência não excede 15 % na maioria dos est...

22 March 2024

• curprev 14:1514:15, 22 March 2024‎ DG Regio talk contribs‎ 82,202 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.7084593487297994

20 December 2023

• curprev 16:5616:56, 20 December 2023‎ DG Regio talk contribs‎ 81,914 bytes +8‎ ‎Changed an Item

12 June 2023

• curprev 14:0514:05, 12 June 2023‎ DG Regio talk contribs‎ 81,906 bytes +540‎ ‎Changed an Item

10 June 2023

• curprev 06:4706:47, 10 June 2023‎ Admin talk contribs‎ 81,366 bytes +437‎ BatchIngestion

4 August 2022

• curprev 09:1809:18, 4 August 2022‎ DG Regio talk contribs‎ 80,929 bytes +56,057‎ ‎Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

• curprev 13:0813:08, 16 January 2022‎ DG Regio talk contribs‎ 24,872 bytes +2,893‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

17 December 2021

• curprev 13:0213:02, 17 December 2021‎ DG Regio talk contribs‎ 21,979 bytes +2,901‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

9 December 2021

• curprev 09:3909:39, 9 December 2021‎ DG Regio talk contribs‎ 19,078 bytes +2,935‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

4 December 2021

• curprev 10:3410:34, 4 December 2021‎ DG Regio talk contribs‎ 16,143 bytes +3,042‎ ‎Changed label, description and/or aliases in fr, and other parts: Adding French translations

12 October 2021

• curprev 17:2117:21, 12 October 2021‎ DG Regio talk contribs‎ 13,101 bytes +2,589‎ ‎Created claim: summary (P836): Allogeneic transplantation is the only therapeutic option for many patients with malignant haemopathies. Its results are limited by its high toxicity, with graft-versus-host disease (GHD) being the main cause of morbidity and mortality. GVHD occurs in 30-70 % of patients; of these up to 80 % do not respond or relapse after first line of treatment (corticoids), and their survival does not exceed 15 % in most studies. Mesenchymal stromal cells (MS...
• curprev 17:2117:21, 12 October 2021‎ DG Regio talk contribs‎ 10,512 bytes −2,589‎ ‎Removed claim: summary (P836): Allogeneic transplantation is the only therapeutic option for many patients with malignant haemopathies. Its results are limited by its high toxicity, with graft-versus-host disease (GHD) being the main cause of morbidity and mortality. GVHD occurs in 30-70 % of patients; of these up to 80 % do not respond or relapse after first line of treatment (corticoids), and their survival does not exceed 15 % in most studies. Mesenchymal stromal cells (...
• curprev 16:4416:44, 12 October 2021‎ DG Regio talk contribs‎ 13,101 bytes +154‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 16:4416:44, 12 October 2021‎ DG Regio talk contribs‎ 12,947 bytes +2,589‎ ‎Created claim: summary (P836): Allogeneic transplantation is the only therapeutic option for many patients with malignant haemopathies. Its results are limited by its high toxicity, with graft-versus-host disease (GHD) being the main cause of morbidity and mortality. GVHD occurs in 30-70 % of patients; of these up to 80 % do not respond or relapse after first line of treatment (corticoids), and their survival does not exceed 15 % in most studies. Mesenchymal stromal cells (MS...

10 October 2021

• curprev 17:4717:47, 10 October 2021‎ DG Regio talk contribs‎ 10,358 bytes +427‎ ‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates

9 October 2021

• curprev 13:0413:04, 9 October 2021‎ DG Regio talk contribs‎ 9,931 bytes +499‎ ‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location

8 October 2021

• curprev 06:3606:36, 8 October 2021‎ DG Regio talk contribs‎ 9,432 bytes −10‎ ‎Changed label, description and/or aliases in en
• curprev 06:3606:36, 8 October 2021‎ DG Regio talk contribs‎ 9,442 bytes +9,442‎ ‎Created a new Item